Date: 2016-11-08
Type of information: Financing round
Company: Curevac (Germany)
Investors: Baden-Württembergische Versorgungsanstalt für Ärzt (Germany) Zahnärzte und Tierärzte (via the LBBW Asset Management Investmentgesellschaft (Germany) Landeskreditbank Baden-Württemberg (Germany)
Amount: $29.5 million
Funding type: financing round
Planned used: These funds will be used to advance the development of its messenger RNA (mRNA) product portfolio.
Others:
Therapeutic area: